Myriad Genetics Inc (MYGN)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

320 WAKARA WAY SALT LAKE CITY, UT 84108

Myriad Genetics Inc., is a leading genetic testing and precision medicine company dedicated to transforming patient lives worldwide. Myriad discovers and commercializes genetic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.

Data as of 2021-07-19 08:17:29 -0400
Market Cap2.372 Billion Shares Outstanding77.052 Million Avg 30-day Volume821.657 Thousand
P/E Ratio-12.22272 Dividend Yield EPS-2.6
Price/Sales3.97 Debt to Equity1.59 EBITDA-83.8 Million
Price to Book Value2.61 Forward PE-0.83 Enterprise Value2.437 Billion
Total Cash160.4 Million Current Debt133.7 Million Gross Profit416.9 Million
BETA1.4906 52-week High/Low34.02 / 11.32 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -58.2259
Data provided by IEX Cloud
View SEC Filings from MYGN instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) 0 (0.0%)
Funds Holding: 193 186 3.76% 44 (2.58%) 48 (2.79%) -8.33%
13F shares: 73.552 Million 75.446 Million -2.51% 20.809 Million 26.172 Million -20.49%
% Ownership 97.7955 27.668 34.7978 -20.49%
New Positions: 35 25 40.0% 8 8 0.0%
Increased Positions 53 58 -8.62% 12 13 -7.69%
Closed Positions 27 26 3.85% 12 16 -25.0%
Reduced Positions 73 67 8.96% 20 19 5.26%
Total Calls 180.255 Thousand 212.697 Thousand -15.25% 52.1 Thousand 70.1 Thousand -25.68%
Total Puts 85.002 Thousand 146.924 Thousand -42.15% 61 Thousand 53.8 Thousand 13.38%
PUT/CALL Ratio 0.47 0.69 -31.88% 1.17 0.77 51.95%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MYGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYGN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

276.1 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

232.4 Thousand total shares from 14 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LANCHBURY JERRY S CHIEF SCIENTIFIC OFFICER

  • Officer
540,845 2021-07-12 13

SPIEGELMAN DANIEL K

  • Director
23,129 2021-06-17 5

DREISMANN HEINRICH

  • Director
83,527 2021-06-03 2

PHANSTIEL S. LOUISE

  • Director
100,527 2021-06-03 3

LANGER DENNIS

  • Director
89,527 2021-06-03 2

NEWCOMER LEE NISLEY

  • Director
40,424 2021-06-03 2

REITAN COLLEEN F

  • Director
40,424 2021-06-03 2

SKOVRONSKY DANIEL

  • Director
37,889 2021-06-03 3

KUMAR RASHMI

  • Director
36,771 2021-06-03 3

HART JAYNE B. CHIEF PEOPLE OFFICER

  • Officer
81,210 2021-05-28 7

HAAS KEVIN RICHARD CHIEF TECHNOLOGY OFFICER

  • Officer
56,113 2021-05-28 4

PARKINSON PAUL FMR EVP STRATEGY & INNOVATION

  • Officer
No longer subject to file 2021-05-14 7

LAMBERT NICOLE SEE REMARKS

  • Officer
129,119 2021-04-19 6

JACKSON BENJAMIN FORMER E.V.P., GENERAL COUNSEL

  • Officer
No longer subject to file 2021-04-12 6

SANTA ERIC CHIEF GROWTH OFFICER

  • Officer
16,420 2021-04-01 2

RIGGSBEE RICHARD BRYAN CHIEF FINANCIAL OFFICER

  • Officer
339,925 2021-03-24 6

VERRATTI MARK PRESIDENT, MYRIAD NEUROSCIENCE

  • Officer
157,130 2021-03-24 5

DIAZ PAUL J PRESIDENT AND CEO

  • Officer
  • Director
458,869 2021-03-24 3

ANCONA MARGARET SVP ENTERPRISE TRANSFORMATION

  • Officer
0 2021-02-18 2

FORD ALEXANDER CHIEF OPERATING OFFICER

  • Officer
169,040 2020-09-30 4

GILBERT WALTER PHD

  • Director
54,150 2019-12-13 0

BEST LAWRENCE C

  • Director
60,790 2019-12-05 0

HENDERSON JOHN T

  • Director
78,090 2019-12-05 0

CAPONE MARK CHRISTOPHER PRESIDENT & C.E.O.

  • Officer
522,216 2019-09-30 0

KING GARY A. EXEC. VP INTERNATIONAL OPS

  • Officer
148,397 2019-09-30 0

MCDADE RALPH L PRESIDENT MYRIAD RBM, INC.

  • Officer
142,095 2019-09-30 0

TOBIN BERNARD PRESIDENT CRESCENDO BIOSCIENCE

  • Officer
160,636 2019-09-30 0

MARSH RICHARD M E.V.P., GENERAL COUNSEL

  • Officer
144,174 2018-09-30 0

SANDERS WALTER LLOYD PRESIDENT MYRIAD ONCOLOGY

  • Officer
36,195 2018-09-30 0

WENSTRUP RICHARD CHIEF MEDICAL OFFICER

  • Officer
50,207 2016-09-30 0

DROSOS VIRGINIA PRESIDENT ASSUREX HEALTH

  • Officer
50,000 2016-09-14 0

MELDRUM PETER D PRESIDENT & C.E.O.

  • Officer
  • Director
10,869 2014-11-05 0

EVANS JAMES S CHIEF FINANCIAL OFFICER

  • Officer
48,128 2014-09-30 0

HARRISON ROBERT GARDNER CHIEF INFORMATION OFFICER

  • Officer
25,844 2014-09-17 0

ROGERS RONALD S. EXEC VP CORP COMMUNICATIONS

  • Officer
16,000 2014-09-17 0

HAGSTROM WILLIAM A PRES. CRESCENDO BIOSCIENCE

  • Officer
0 2014-02-28 0

BENSON T CRAIG PRESIDENT, MYRIAD RBM

  • Officer
0 2013-09-17 0

WILSON LINDA S

  • Director
2,500 2010-01-07 0

SKOLNICK MARK H CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
549,001 2009-11-04 0

BELLE GERALD P.

  • Director
0 2009-11-04 0

CRITCHFIELD GREGORY C PRESIDENT MYRIAD GENETIC LABS

  • Officer
0 2009-09-15 0

HOBDEN ADRIAN N PRES. MYRIAD PHARMACEUTICALS

  • Officer
234,071 2009-06-08 0

LASLIE W WAYNE CHIEF OPERATING OFFICER, MPI

  • Officer
44,260 2009-05-08 0

ATTIYEH ROBERT S

  • Director
0 2008-11-13 0

HOCKETT WILLIAM A III V. P. OF CORP COMMUNICATIONS

  • Officer
0 2008-09-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 M 40,000 d 16,225 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 S 3,295 $33.69 d 232,550 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 M 3,295 d 56,225 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 S 40,000 $33.74 d 232,550 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 M 3,295 $26.49 a 235,845 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-13 M 40,000 $26.49 a 272,550 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 M 36,705 d 72,815 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 M 13,295 $26.49 a 245,845 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 S 36,705 $33.55 d 232,550 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 M 13,295 d 59,520 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 S 13,295 $33.55 d 232,550 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-14 17:44:33 -0400 2021-07-12 M 36,705 $26.49 a 269,255 direct yes -1.5035 2.9111 2.9111 6 -4.1267 3

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 5,603 d 109,520 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 S 17,692 $32.47 d 232,550 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 5,603 $26.49 a 238,153 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 26,705 d 115,123 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 17,692 $19.47 a 250,242 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 S 26,705 $32.79 d 232,550 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 17,692 d 0 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 S 5,603 $32.29 d 232,550 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-12 18:16:38 -0400 2021-07-09 M 26,705 $26.49 a 259,255 direct yes -3.6419 -4.7951 0.0 1 -9.044 5

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 S 1,884 $31.99 d 232,550 direct yes 2.626 -7.0631 2.626 2 -7.0631 6

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 M 30,424 $26.49 a 262,974 direct yes 2.626 -7.0631 2.626 2 -7.0631 6

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 M 30,424 d 141,828 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 M 1,884 $26.49 a 234,434 direct yes 2.626 -7.0631 2.626 2 -7.0631 6

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 M 1,884 d 0 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-07-08 17:50:44 -0400 2021-07-07 S 30,424 $32.29 d 232,550 direct yes 2.626 -7.0631 2.626 2 -7.0631 6

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 1,891 d 1,884 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 S 1,891 $32.23 d 232,550 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 3,973 $26.49 a 236,523 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 3,973 d 172,252 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 S 948 $32.49 d 232,550 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 1,891 $26.49 a 234,441 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 948 d 17,692 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 M 948 $19.47 a 233,498 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-30 17:50:20 -0400 2021-06-28 S 3,973 $32.43 d 232,550 direct yes -0.0319 5.8128 5.8128 6 -0.0319 2

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 S 33,372 $31.61 d 232,550 direct yes 0.361 5.1854 5.1854 6 0.0 1

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 S 21,360 $32.47 d 265,922 direct yes 0.361 5.1854 5.1854 6 0.0 1

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 M 28,640 d 18,640 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 S 28,640 $31.97 d 265,922 direct yes 0.361 5.1854 5.1854 6 0.0 1

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 M 21,360 $19.47 a 287,282 direct yes 0.361 5.1854 5.1854 6 0.0 1

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 M 21,360 d 47,280 direct yes

LANCHBURY JERRY S - Officer CHIEF SCIENTIFIC OFFICER

2021-06-28 20:00:59 -0400 2021-06-25 M 28,640 $19.47 a 294,562 direct yes 0.361 5.1854 5.1854 6 0.0 1

SPIEGELMAN DANIEL K - Director

2021-06-17 17:41:51 -0400 2021-06-17 S 3,139 $30.52 d 23,129 direct yes 2.2719 13.9811 13.9811 6 0.0 1

SKOVRONSKY DANIEL - Director

2021-06-04 20:34:16 -0400 2021-06-03 A 12,848 a 37,889 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

KUMAR RASHMI - Director

2021-06-04 19:14:44 -0400 2021-06-03 A 12,848 a 36,771 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

LANGER DENNIS - Director

2021-06-04 18:58:35 -0400 2021-06-03 A 12,848 a 89,527 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

REITAN COLLEEN F - Director

2021-06-04 19:43:36 -0400 2021-06-03 A 12,848 a 40,424 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

SPIEGELMAN DANIEL K - Director

2021-06-04 19:11:07 -0400 2021-06-03 A 12,848 a 26,268 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

DREISMANN HEINRICH - Director

2021-06-04 18:55:15 -0400 2021-06-03 A 12,848 a 83,527 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

PHANSTIEL S. LOUISE - Director

2021-06-04 19:39:12 -0400 2021-06-03 A 12,848 a 79,527 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

NEWCOMER LEE NISLEY - Director

2021-06-04 19:02:42 -0400 2021-06-03 A 12,848 a 40,424 direct 1.5678 2.045 6.9189 15.8828 25 -2.4881 10

HAAS KEVIN RICHARD - Officer CHIEF TECHNOLOGY OFFICER

2021-06-03 18:42:10 -0400 2021-05-28 A 344 $15.86 a 56,113 direct 6.6521 8.0698 8.9422 23.5914 26 0.0 1

SPIEGELMAN DANIEL K - Director

2021-06-01 19:15:40 -0400 2021-05-28 S 7,142 $28.99 d 13,420 direct yes -3.3357 3.726 10.9297 20.6529 28 -3.3357 2

HART JAYNE B. - Officer CHIEF PEOPLE OFFICER

2021-06-03 18:45:34 -0400 2021-05-28 A 1,082 $15.86 a 81,210 direct 6.6521 8.0698 8.9422 23.5914 26 0.0 1

SPIEGELMAN DANIEL K - Director

2021-05-28 18:48:14 -0400 2021-05-27 D 15,889 d 20,562 direct 0.6429 6.4286 13.3929 21.4286 29 -2.7143 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MYRIAD GENETICS INC MYGN 2021-07-23 22:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 21:45:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 21:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 20:45:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 20:15:05 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 19:45:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 19:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 18:45:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 18:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 17:45:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 17:15:02 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 16:45:02 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 16:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 15:45:02 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 15:15:03 UTC -0.1982 0.2782 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 14:45:03 UTC -0.1727 0.2527 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 14:15:03 UTC -0.1727 0.2527 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 13:45:03 UTC -0.1727 0.2527 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 13:15:03 UTC -0.1727 0.2527 3100000
MYRIAD GENETICS INC MYGN 2021-07-23 12:45:03 UTC -0.1727 0.2527 3100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund MYGN -561.0 shares, $-8027.91 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund MYGN -311.0 shares, $-4450.41 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund MYGN -526.0 shares, $-7527.06 2020-03-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund MYGN -2027.0 shares, $-61722.15 2021-03-31 N-PORT

Elevate your investments